Literature DB >> 19157299

[Cloning, expression and purification of allergen arginine kinase from Periplaneta americana and its allergic activity].

Jia-Jie Chen1, Li-Xin Xia, Zhi-Gang Liu, Wen Liu, Kun-Mei Ji.   

Abstract

OBJECTIVE: To clone the gene of arginine kinase (AK) from Periplaneta americana, produce its recombinant protein and investigate its allergenicity.
METHOD: The cDNA of AK was cloned using specific primers from the total RNA of P. americana. The cloned gene was inserted into pMD18-T vector and digested by BamHI and HindIII. The cDNA was sequenced and subcloned into pET-28a expression vector. The cloned AK cDNA gene was expressed in Escherichia coli BL21 (DE3) by IPTG induction. The recombinant AK (rAK) was purified by metal (Ni2+) chelating affinity chromatography. Its allergenicity was examined by both Western blotting and enzyme-linked immunosorbent assay (ELISA). RESULT: The cloned cDNA ORF sequence (Accession no. EU429466) contained 1068 bp and encoded 365 amino acids. Its sequence homology with the published one (Accession no. AY563004) was 99.9% at nucleotide level. The allergen rAK was highly expressed in E. coli BL21 (DE3) as a soluble protein mainly with the molecular weight of about Mr 45000 under induction of IPTG and purified by 6-His-tag purification system. Both in the non-denaturalization and denaturalization conditions, the recombinant allergen was identified as its affinity to IgE antibodies from the cockroach-allergic patient sera by Western blotting and ELISA.
CONCLUSION: The recombinant cockroach arginine kinase has been obtained with proper allergenicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19157299

Source DB:  PubMed          Journal:  Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi        ISSN: 1000-7423


  1 in total

1.  Immunological characterization of the American cockroach allergen Per a 9 expressed in baculovirus-infected insect cells.

Authors:  Hai-Wei Yang; Wei Zhang; Wei-Wei Ni; Min Jin; Shao-Heng He; Ji-Fu Wei
Journal:  Cent Eur J Immunol       Date:  2019-09-30       Impact factor: 2.085

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.